Skip to content
  1. Home
  2. Latest news
  3. Caring & giving
  4. How Johnson & Johnson and the Stephen Siller Tunnel to Towers Foundation are making a difference for military veterans
Johnson & Johnson Stephen Siller Tunnel to Towers Foundation Tunnel
Members of the military participate in the Tunnel to Towers 5K Run & Walk

How Johnson & Johnson and the Stephen Siller Tunnel to Towers Foundation are making a difference for military veterans

Members of the military participate in the Tunnel to Towers 5K Run & Walk

Support for our nation’s soldiers is part of Johnson & Johnson’s DNA.

In the 1800s, the company was integral to spreading the word about the importance of sterile care for wounds sustained on the battlefield, thanks to its innovations in surgical dressings and sutures. And during the Spanish-American War, Johnson & Johnson did something groundbreaking and continued to pay employees their salaries, and held their positions for them, while they served.

That legacy continues to this day, from policies that make it easier for service members on leave to transition back into their day-to-day lives to partnerships that give them the skills and resources they need to thrive.

Partnerships like the one between Johnson & Johnson and the Stephen Siller Tunnel to Towers Foundation, which was founded in 2001 to help military veterans and first responders and their families.

In honor of the 16th annual Tunnel to Towers 5K Run & Walk on September 24, we’re taking a look at how both organizations have joined forces to be there for service members over the past three years.

Tunnel to Towers infographic

More from Johnson & Johnson

Terra Kremer, Ph.D., is on a mission to create self-sterilizing surgical tools

Since its launch, Johnson & Johnson has focused on helping make surgeries safer. Learn how this analytical microbiologist and her team are continuing in that tradition with a digital app that aims to change the way medical devices are designed and sterilized.

What is lupus?

Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.

This scientist develops targeted treatments for cancer—here’s what drives and inspires him

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.